The distribution of polysialosyl glymnjugates defiied by a monodonal antibody M6704 (M6704 antigen) and of its 0-acetylated counterpart (O-Ac-M6704 antigen) was investigated in human gliomas and in normal adult and fetal central netvous system. Among 32 gliomas, M6704 antigen was confiied to the glioma cell surface and cytoplasmic processes in 21 cases, whereas O-Ac-M6704 antigen was expressed in the Golgi region in 22 cases and at the cell surface in seven cases. In adult tissues M6704 antigen was barely detectable, whereas in fetal tissues it was spatially and temporally expressed at the cell surface and along processes of post-mitotic neurons. The O-Ac-M6704 antigen first appeared in the Golgi regions of neurons at 66 gestational days and increased These results indicate that M6704 antigen is a distinctive component expressed selectively by embryonic neurons during development and by glioma cells. (JHistoctem Cytoctem KEY WORDS: Polysialoglycoprote~ C-series polysialoganglioside; Human; Central nervous system; Glioma-associated antigen; Developmental antigen; Immunohistochemistry; Double-labeling immunohistochemistry; Thin-layer chromatography: Polyacrylamide gel electrophoresis.
Introduction
In the nervous system, glycoconjugates including glycolipids and glycoproteins in cell surface membranes are involved in regulation of cell proliferation, differentiation, and neoplastic transformation (1) (2) (3) . Among various carbohydrate residues, polysialic acid is unique in that it consists of an extended homopolymer of sialic acids such as N-acetylneuraminic acid (NeuAc), joined intemdy by a2-8 ketosidic linkages (4) and, in many vertebrate species, is found exclusively on neural cell adhesion molecule (N-CAM) (4-8) and C-series polysialogangliosides (9) (10) (11) (12) . The hydroxy groups of these molecules can be 0-acetylated at different positions of the sialic acids, and the 0-acetyl ester at the 9-position of the sialic acids especially appears to be developmentally related, tissue specific, and sometimes oncofetal (13) (14) (15) (16) (17) (18) .
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In previous studies, developmental changes of C-series polysialogangliosides during encephalogenesis of chick and rat were analyzed with a monoclonal antibody (MAb) M6704 (10) (11) (12) and the antigens, including their 0-acetylated counterparts, were found to be embryonic types of gangliosides in these species. Although C-series polysialogangliosides are thought to be a candidate for embryonic or oncodevelopmental antigens in human, little is known about the expression of the antigens in human CNS, including glioma tissues (19) (20) (21) (22) .
This study was undertaken to elucidate the immunohistochemical expression of the polysialosyl glycoconjugates defined by MAb M6704, designated as M6704 antigen, in human gliomas as well as in fetal development and normal adult CNS. In the fetal CNS the distribution of the M6704 antigen was compared with that of glial fibrillary acidic protein (GFAP), a specific marker for astrocytes (23, 24) . Furthermore, expression and distribution ofthe M6704 antigen and its 0-acetylated counterpart, the O-Ac-M6704 antigen, were studied by simultaneous demonstration with doublelabeling immunohistochemistry. Analyses by thin-layer chromatography (TLC) immunostaining and SDS-PAGE immunoblotting procedures were also performed to characterize the M6704 antigen.
Materials and Methods
Cases. Surgical specimens from 32 patients with glioma operated on at Shinshu University Hospital, Matsumoto, Japan, were investigated. The patients' clinicopathological status are listed in 'Igble 1. The histopathological diagnosis and gradings were made in all cases according to the criteria of the World Health Organization-Histological Typing of Tumours of the Central Nervous System (1979) , and the clinical stages were determined according to the guideline of International Union Against Cancer-TNM Atlas (Illustrated Guide to the TNM/pTNM-classification of Malignant Tumours) (1989) . Furthermore, cerebrums and spinal cords of five normal human adults and seven fetuses (49,61.66,71,79,87,98 days of gestation based on the mother's last menstrual period) obtained by therapeutic abortions or at autopsy were investigated. nized C-series polysialogangliosides including GT3, GT2, GTlc, GQlc, and GPlc. However, MAb M6704 was unreactive with the uisialosyl residue having 0-acetyl ester. The synthetic pathway of C-series polysialogangliosides is shown in Figure 1 . A rabbit polyclonal antibody against GFAP and a mouse MAb against N-CAM were purchased from Dakopatts (Glosuup, Denmark).
Immunohistochemistry. All tissue samples were fixed for 24 hr in a cold 4% paraformaldehyde solution buffered with 0.1 M phosphate buffer (pH 7.4). embedded in paraffin, and sectioned serially at 3-pm thickness for the following immunohistochemical procedures in addition to hematoxylin and eosin staining.
The indirect immunoperoxidase technique was performed to examine distribution of the M6704 antigen in all cases including the adult and fetal neural tissues (25) . In fetal tissues immunohistochemical staining for GFAP was also performed to elucidate the relationship between the M6704 anti-Antibodies. A mouse IgG3 MAb, M6704, raised against the crude membrane fractions of the neural tube and somite collected from 3-dayold chick embryos, was used. This MAb detected polysialosyl glycoconjugates, and its characterization was described elsewhere in detail (10,ll) . In brief, MAb M6704 required at least the presence of trisialosyl residue, NeuAc(a2-8)NeuAc(a2-8)NeuAc(a2-3)-galactose (Gal) for binding, and so recog-gen and-GFAP. Deparaffinized and hydrated-sections were sequentially treated with 0.3% H202 in absolute methanol for 30 min, 10% normal goat serum in 10 mM PBS (pH 7.2) for 30 min, and reacted with MAb M6704 or anti-GFAP polyclonal antibody at 4'C overnight. Both primary antibodies were diluted 1:lOO in PBS containing 1% bovine serum albumin (BSA-PBS). After rinsing with PBS, horseradish peroxidase (HRP) con- jugated F(ab)-fragment of goat anti-mouse or anti-rabbit IgG antibody diluted 1:lOO in BSA-PBS was applied for 1 hr at room temperature. The second antibodies were purchased from Medical Biological Laboratories (Nagoya, Japan). After another rinse with PBS the peroxidase activity was visualized as a brown color with diaminobenzidinc/H202 solution. Counterstaining was carried out with methyl green when the staining did not proceed to the double-labeling immunohistochemistry. A control step was performed by omitting the primary antibodies from BSA-PBS when incubating overnight, and no specific staining was found.
For simultaneous demonstration of the M6704 antigen and the O-Ac-M6704 antigen, double-labeling technique interposed with saponification in situ was performed. After the indirect immunoperoxidase staining with MAb M6704 saponification with 1% KOH in PBS was done for 15 min (26) . This saponification imparted positive immunoreactivity with MAb M6704 to the O-Ac-M6704 antigen through removal of the 0-acetyl esters from sialic acids (11) . The second immunohistochemistry was carried out with the alkaline phosphatase procedure according to the method of Nanba et al. (27) with slight modification. After another incubation of the tissue sections with MAb M6704 diluted 1:100 in 50 mM Tris-HC1-buffered saline (TBS) (pH 7.6) containing l% BSA (BSA-TBS) overnight at 4°C followed by rinsing with TBS, rabbit anti-mouse IgG conjugated to alkaline phosphatase (Dakopatts) diluted 1:40 in BSA-TBS was subsequently applied. After another rinse with TBS, the alkaline phosphatase activity was visualized as a red color with 0.025% naphthol AS-BI phosphate, sodium salt (Sigma; St Louis, MO) as a substrate and 0.01% hexazodzed new fuchsin (Merck; Darmstadt, Germany) as a coupler in 0.2 M 3k-HC1 buffer @H 8.2). After counterstaining with hematoxylin the specimens were cleared in xylene and mounted. The M6704 antigen could be seen as a brown color and the 0-Ac-M6704 antigen as a red color. A red-brown color indicated the simultaneous presence of both antigens in the same cell component. A control step was performed by omitting MAb M6704 from BSA-TBS when incubating overnight, and no specific staining was found. Endogenous alkaline phosphatase activity was undetectable in the tissue specimens.
Pre-treatment of Tissue Sections with Organic Solvent. For the possible extraction of glycosphingolipids from the tissue sections, they were immersed in the solvent system of chloroform/methanol(2:1 by volume) for 4 hr at room temperature before indirect immunoperoxidase staining with' MAb M6704. Pre-treatment was omitted in the control sections.
Neuraminidase Digestion. For removal of sialic acids, digestion with neuraminidase from Arthrobacter ureajzcienr (Nakalai Tesque; Kyoto, Japan) was carried out (26) . Tissue sections were incubated with a solution containing 1 U/ml of neuraminidase in 50 mM phosphate buffer (PB) (pH 7) for 4 hr at 37'C before indirect immunoperoxidase staining with MAb M6704. A control step was performed by omitting the neuraminidase from PB when incubating at 37'C.
Immunochemisay. Immunochemical evaluations were conducted in five gliomas (Cases 5, 8, 18, 21. 22) by TLC immunostaining procedure and in four (Cases 5 , 8, 21, 22) by SDS-PAGE immunoblotting procedure (Tible l). Immunohistochemically, four cases ( 5 , 8, 18, 22) were positive for the M6704 antigen, and one case (21) was negative. Cerebrums and spinal cords from two adult cases were also analyzed by TLC immunostaining and SDS-PAGE immunoblotting procedures. As soon as the fresh materials were resected they were stored at -8O'C until extraction.
The specimens were first lyophilized (dry weight 7.5-300 mg), chloroform/methanol/water (4:8:3 by volume) was added (28) . and the tissues were homogenized. Reextraction was performed with a solvent mixture of similar composition. Supernatants were subjected to analysis for C-series polysialogangliosides and residues to analysis for polysialoglycoproteins. The supernatants were evaporated and dissolved in chloroform/methanol/water (15:30:4 by volume). The lipid extracts were sequentially separated into neutral lipids eluted with 10 volumes of chloroform/methanol/wter (15:304 by volume) and acidic lipids eluted with 10 volumes of chloroformlmetha-no110.8 M sodium acetate (15:30:4 by volume) by a DEE-Sephadex A-25 column (Pharmacia: Uppsala, Sweden). The acidic lipids were desalted with a Sep-Pak Cl8 cartridge (Waters; Milford, MA) (29) . The gangliosides (2) (3) (4) wm as lipid-bound sialic acids) were subjected to the following TLC immunostaining procedure. As for the residues, 2% SDS containing 10% 2-mercaptoethanol in 125 mM 3is-HC1 buffer (pH 6.8) was added and they were heated in boiling water for 3 min.
TLC-immunostaining of C-series polysialogangliosides on TLC plates (Polygram Si1 G) (Macherey-Nagel; Doren, Germany) was performed as described previously (10) . Briefly, the plates were first developed with the solvent system of chloroform/methanol/12 mM MgC12 /conc. N h O H (50:40:7:3 by volume). After drying they were developed again in the same direction with the solvent system of chloroform/methanol/12 mM MgC12 (5:4:1 by volume). The dried plates were washed in PBS containing 1% egg albumin and 1% polyvinylpyrrolidone (Solution A) for 1 hr and then applied with MAb M6704 diluted 1:200 in Solution A at 30'C for 2 hr. After rinsing several times with PBS containing 0.02% Tween 80, goat mtimouse IgG [F(ab')2 fragment] conjugated with HRF' (Cappel; West Chester, PA) diluted 1:loOO in PBS containing 3% polyvinylpyrrolidone was applied at 30'C for 2 hr. After another rinse the peroxidase activity was visualized with 4-chloro-l-naphtholIH~02 solution. SDS-PAGE of glycoproteins was carried out by the method of Laemmli (30) . An aliquot of each sample, containing about 10 pg as protein, was applied to 8% polyacrylamide gels purchased from Toray (Tokyo, Japan). Molecular weight standards were purchased from Bio-Rad (Richmond, CA). The proteins on a gel were electrophoretically transferred to nitrocellulose membrane or polyvinylidene difluoride membrane according to the method of Towbin et al. (31) . The membranes were treated in 10 mM TBS (pH 8) containing 0.05% Tween 20 (Solution B) and then incubated with Solution B containing MAb M6704 at a dilution of 1:100 or anti-N-CAM antibody at a dilution of 1:50 at 4'C overnight. The sheets were washed three times with Solution B. and goat anti-mouse IgG antibody [F(ab) fragment] conjugated with HRP (Medical Biological Laboratories) diluted 1:IOO in Solution B was applied. After another rinse with Solution B the peroxidase activity was visualized with diaminobenzidinelH202 solution.
Results

Immunohistochemical Expression of M6704 Antigen in Human Gliomas
The results of the indirect immunoperoxidase staining with MAb M6704 on human gliomas are indicated in Table 1 . In 32 gliomas examined, 21 cases (66%) were positive for M6704 antigen in various degrees, regardless of their histological type (astrocytoma Grades 1 and 2, 50%; astrocytoma Grade 3 , 56%; glioblastoma, 86%; oligodendroglioma, 67%; ependymoma, 67%; medulloblastoma, 100%). site of location (cerebrum, 64%; cerebellum, 67%; pons, 50%; spinal cord, lOOYo), and clinical stage (TI, 67%; T2, 56%; T3. 71%; T4, 64%) ( Figure 2 ). M6704 antigen was found along cell surface membrane and/or cytoplasmic processes of tumor cells and expressed heterogeneously within individual specimens, but could not be detected in the cytoplasm of glioma cells. In other tissue components, including vascular endothelial cells, M6704 antigen was not found.
None of the immunoreactivity with MAb M6704 was influenced by pre-treatment with the organic solvent, but all was completely abolished after pre-treatment with the neuraminidase.
Immunohistochemical Expression of M6704
Antigen in Adult and Fetal CNS Table 2 shows the immunohistochemical results with MAb M6704 in adult and fetal CNS. In adult cerebrums and spinal cords, most of the neurons, and all glial cells were negative for M6704 antigen, but it was detected in trace amounts in the neuropil of the gray matter and rarely in the Golgi regions of the neurons (Figures 3h  and 3i ). No antigen was detected in other tissue components, including vascular endothelial cells.
In fetal spinal cord M6704 antigen was strongly expressed in cell surfaces and processes of post-mitotic immature neurons in the intermediate zone and in cell processes in the marginal zone at 49 gestational days, but decreased gradually on further differentiation and development. In the 98-day-old fetus M6704 antigen was restricted to the surface membrane of the anterior horn cells and to the marginal zone. The ventricular cells and the radially oriented fibers were negative for M6704 antigen in all developmental stages examined (Figures 3a-3f ). Immunoreactivity with MAb M6704 in the cerebral hemisphere was similar to that in the spinal cord. In the cerebral hemisphere of the 61-day-old fetus M6704 antigen was found along cell surface and processes of post-mitotic neurons from the intermediate zone to the marginal zone and decreased on further differentiation and development. The ventricular cells themselves did not express the M6704 antigen in the 61-and 98-day-old fetuses. Other tissue components, including the vascular endothelial cells in the fetal tissues, were negative for M6704 antigen. Immunoreactivity is seen on cell surfaces andlor processes.
d Immunoreactivity is seen in Golgi regions.
None of the immunoreactivity with MAb M6704 was influenced by pre-treatment with the organic solvent, but all was completely abolished after pre-treatment with neuraminidase.
Immunohistochemical Comparison between MG704 Antigen and GFAP in Fetal CNS
In developing spinal cords from 49 to 61 gestational days, GFAPpositive cells were not seen. Focal but definite GFAP immunoreactivity began to appear at a few ventricular cells of 66-day-old fetus and later extended into the intermediate zone. At 98 gestational days about half of the ventricular cells, radially oriented fibers, short cell processes of the intermediate zone, and subpial glial processes were strongly positive for GFAP ( Figure 3g ). In fetal cerebrums from 61 to 91 gestational days, GFAP-positive cells were not seen. The pattern of distribution of GFAP and M6704 antigen in the developing neural tissues was quite distinct.
Simultaneous Demonstration of MG704 Antigen and 0-Ac-MG704 Antigen in Gliomas and in Fetal and Adult CNS
As shown in Tiable 1, O-Ac-M6704 antigen was demonstrated in the Golgi region of the glioma cells regardless of the presence of M6704 antigen in 22 cases (69%) of gliomas (astrocytoma Grades 1 and 2, 38%; astrocytoma Grade 3, 78%; glioblastoma, loo%, oligodendroglioma, 100%; ependymoma, 67%; medulloblastoma, 0 % ) (Figures 4a, 4c, and 4d ). In seven cases (22%) O-Ac-M6704 antigen could be detected along the cell surface irrespective of M6704 antigen on the cell surface or of O-Ac-M6704 antigen in the Golgi region. This staining pattern was more obvious in highgrade than in low-grade astrocytomas (Figure 4d ). In two cases (6%), however, only M6704 antigen was noted on the cell surface of the glioma cells (Figure 4b ). In other tissue components, only the Golgi region of the vascular endothelial cells was almost always positive for the 0-Ac-M6704 antigen. Table 2 shows the expression of 0-Ac-M6704 antigen in fetal and adult CNS. In fetal neural tissues O-Ac-M6704 antigen began to appear at the Golgi regions, but not on the cell surface, of the post-mitotic neurons in spinal cord of 66-day-old fetus, and was enhanced gradually with further development (Figures 4e and 4f) . However, the ventricular cells and the glial cells were negative for O-Ac-M6704 antigen. In the cerebrums of the 61-and 98-day-old fetuses, on the other hand, 0-Ac-M6704 antigen was undetectable.
The vascular endothelial cells in the fetal neural tissues were negative for O-Ac-M6704 antigen.
In normal adult cerebrums and spinal cords, O-Ac-M6704 antigen could be ubiquitously and clearly seen at the Golgi regions but not on cell surface membranes of the neurons, and was weakly expressed in the neuropil of the gray matter (Figure 4g ). Astrocytes and oligodendroglia did not express O-Ac-M6704 antigen (Figure 4g ), but the Golgi region of the vascular endothelial cells was occasionally positive for O-Ac-M6704 antigen. Figure 5 shows the TLC hmunostaining of C-series polysialogangliosides from human gliomas with MAb M6704. In the five cases examined strong and specific binding of C-series polysialoganglioside GT3 was obtained in four cases, which were immunohistochemically positive for M6704 antigen. Moreover, minor bands indicated the presence of GTlc, GQlc and GPlc in three cases.
Detection of C-series Polysialoganghosides in Human Gliomas and Adult CNS
In the two adult cases examined, no detectable bands were found in the cerebrums and spinal cords (data not shown). Figure 6a demonstrates the SDS-PAGE immunoblotting of polysialoglycoproteins from human gliomas and normal adult CNS with MAb M6704. In the four cases examined, a major band at 51 KD was found in three cases that were immunohistochemically positive for M6704 antigen. Furthermore, several minor bands at less than 50 KD were noted in two cases. In the two adult cases examined, no detectable bands were found in the cerebrums and spinal cords. Figure 6b demonstrates the SDS-PAGE immunoblotting of N-CAM from human gliomas and normal adult CNS. No detectable bands were found in the gliomas. In the two adult cases examined, N-CAMS (180 KD, 140 KD, 120 KD) were demonstrated in the cerebrums and N-CAM of 120 KD was detected faintly in the spinal cords.
Detection of Polysialoglycoproteins and N-CAM in Human Gliomas and Adult CNS
Discussion
The present study has shown that the polysialosyl glycoconjugates recognized by MAb M6704 are heterogeneously expressed in about 60% of the gliomas. M6704 antigen was localized in the cell surface and cytoplasmic processes of glioma cells. Among astrocytederived gliomas. the positive cases were more frequent in glioblastoma than in other astrocytomas (Grades 1-3) and there was no relationship between the expression of M6704 antigen and the clinical stage. For non-astrocytic gliomas, 75% of cases were positive for M6704 antigen, but expression of M6704 antigen seemed not to be related to the histological type or the clinical stage. Since M6704 antigen was scarcely detectable in adult CNS. it could be considered to be glioma-associated. Interestingly, M6704 antigen was spatially and temporally expressed on post-mitotic immature neurons but not on the GFAP-positive astrocytes in human fetal neural tissues. Therefore, M6704 antigen appears to be not only a glioma-associated antigen but also a developmental antigen for neurons, and is probably related to their cytogenesis because both neurons and macroglial cells are generated from ultimate progenitors, i.e.. the ventricular cells (32) . Therefore, M6704 antigen is a useful marker for studying cell differentiation and tumorigenesis in the human CNS. The appearance of GFAP in developing neural tissues indicated here is consistent with other previous reports (23.24) . GFAP is the most specific and sensitive marker for astrocytes, but not the earliest one for detecting astrocyte differentiation (23) . Further study is required to ascertain whether M6704 antigen is present in the less mature, GFAP-negative astrocytes. Among A-and B-series gangliosides, it is well known that simple gangliosides (GM3, GM2, GD2, and in particular GD3) increase and, conversely, complex gangliosides (the gangliotetraose series) decrease in gliomas in contrast to normal brain tissues (2) . However, this study is the first to demonstrate the presence of C-series polysialogangliosides in surgically removed human glioma tissues. Although C-series polysialogangliosides including 9-0acetylated counterparts could be embryonic-type gangliosides in the CNS of chick and rat (10) (11) (12) 19, 33) , they have received very lit- (34) (35) (36) , and these authors did not confirm whether or not the AZB5-binding molecules in the glioma cells corresponded to C-series polysialogangliosides. Dubois et al. (19) reported the presence of GT3 in five of seven human melanoma cell lines by TLC immunostaining with MAb 18B8 directed against GT3, but they did not examine human glioma cells. Among various gangliosides of the normal adult CNS, C-series polysialogangliosides are major constituents in fish but extremely minor ones or undetectable in higher vertebrate species (human, bovine, rat, and chick) (9) (10) (11) 37) , and this study confirms that C-series polysialogangliosides, including GT3, could not be found in human adult cerebrums and spinal cords. In human embryonic cerebellum, however. GQlc could be detected by TLC immunostaining with MAb 4211 specific for GTk, GQlc. GPlc and ' G H (38) . Taken together, these studies indicate that, in human, C-series polysialogangliosides could be expressed in association not only with melanomas but also with gliomas. MAb M6704 binds to C-series polysialogangliosides but not to A-series, B-series and a-series gangliosides (IO). However, as shown in this study, the organic solvent-stable nature of M6704 antigen suggests that it belongs to glycoprotein rather than glycosphingolipid. Actually, polysialoglycoproteins with molecular masses of 51 KD and below, which have not been described thus far, were determined in human glioma tissues but not in adult neural tissues. Sialic acids might be involved in the antigenic determinant of the M6704 antigen, since the antigen was sensitive to neuraminidase.
As shown by SDS-PAGE immunoblotting analysis, the immunochemical difference between the polysialoglycoproteins defined by MAb M6704 and N-CAM indicates that both molecules were quite distinct from each other. Among glycoproteins in many vertebrate species, polysialic acid is well known to occur in N-CAM exclusively (4) (5) (6) (7) (8) . N-CAM is an integral membrane glycoprotein promoting cell-to-cell adhesion through a homophilic binding mechanism, and biochemically consists of three major polypeptides with molecular masses of 180 KD, 140 KD, and 120 KD, which are generated by altemative RNA splicing from a single gene (4) (5) (6) . N-CAM is expressed in cells of neural crest lineage, such as neurons, glial cells, chromaffin cells of adrenal medulla, and neuroendocrine cells, and in various tumors including neuroblastoma, Wilms' tumor, and small-cell lung cancer (4, 7, 8) . As indicated here, lack of M6704 antigen in the glial cells also indicates that it is distinct from N-CAM. In addition to human gliomas, polysialoglycoproteins with low molecular masses (18 KD, 30 KD, 52 KD) defined by MAb M6704 could be found in three mouse neuroblastoma cell lines, Neuro 2a, NS-ZOY, and N1E-115 (unpublished results). Further studies are needed to elucidate the chemical structure of the novel polysialoglycoproteins in detail and their physiological functions in the CNS.
During ontogeny of the neurons, M6704 antigen could be converted to the O-Ac-M6704 antigen in association with neuronal differentiation, as shown by double-labeling immunohistochemistry. In this staining procedure the saponification was indispensable before detection of the O-Ac-M6704 antigen with MAb M6704 because it does not react with trisialosyl residues having 0-acetyl ester (11) . In the Golgi regions the O-Ac-M6704 antigen might be created from M6704 antigen by 0-acetylation of M6704 antigen. The 0-acetyl ester of the 0-Ac-M6704 antigen was probably added to the 9-position of the terminal sialic acid, since the Golgi regions expressing the O-Ac-M6704 antigen were positive for MAb 493D4 which recognized the 9-0-acetylated sialic acids (unpublished results). It appears that when 0-acetylation of M6704 antigen was incomplete, M6704 antigen was always associated with the Golgi regions, as found in a small number of the adult neurons. The 9-position of polysialic acids has been reported to be 0-acetylated under oncodevelopmental conditions (13, 17, 18) . O-Ac-M6704 antigen was not, however, oncodevelopmentally regulated because it continued to be expressed in neurons from 66 gestational days to adulthood.
Indeed, M6704 antigen and 0-Ac-M6704 antigen, both of which were distinctive markers for neurons but not for glial cells, could be expressed in human gliomas. Although the pathway of biosynthesis and turnover of both antigens in glioma cells could not be proven here, the most likely explanations, which are assumed from the detailed studies of the 0-acetylation of GD3 in human melanoma cells or that of sialic acids in rat liver Golgi vesicles (15) (16) (17) , are as follows: as soon as M6704 antigen was aberrantly synthesized in the Golgi region of the glioma cells in association with oncogenic transformation (39) , it was directly transferred to the cell surface and/or converted to O-Ac-M6704 antigen in the Golgi region. This speculation is supported by the fact that M6704 antigen always appeared on the cell surface of the glioma cells and/or that the Golgi region of the glioma cells expressed only O-Ac-M6704 antigen. For glioma cells expressing O-Ac-M6704 antigen in the Golgi region simultaneously with M6704 antigen in the cell surface, it is also possible that 0-Ac-M6704 antigen in the Golgi region was partially transferred to the cell surface after de-0acetylation. Expression of O-Ac-M6704 antigen in the cell surface, which was found in less differentiated astrocytomas, suggests that O-Ac-M6704 antigen in the Golgi region could be alternatively transferred to the cell surface without de-0-acetylation. Enzymatic regulation involved in 0-acetylation of M6704 antigen or de-0acetylation of O-Ac-M6704 antigen remains to be explored.
